|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.374
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.347
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.319
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.274
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.254
|
Mouse |
|
|
positive regulation of neutrophil apoptotic process
|
GO:0033031 |
1 |
0.226
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.187
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.183
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.178
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.176
|
|
|
|
regulation of neutrophil apoptotic process
|
GO:0033029 |
1 |
0.170
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
4 |
0.163
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.162
|
Human |
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.158
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.154
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.150
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.149
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.143
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.137
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.132
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.131
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.128
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.126
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.119
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.117
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.112
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.111
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.111
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.109
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.104
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.103
|
Human |
|
|
regulation of binding
|
GO:0051098 |
111 |
0.100
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.096
|
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.096
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.094
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.094
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.093
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.093
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.092
|
Mouse |
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.091
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.090
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.090
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.090
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.089
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.088
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.088
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.087
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.087
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.085
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.085
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.085
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.084
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.083
|
Mouse |
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.083
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.083
|
Human |
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.082
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.078
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.076
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.076
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.074
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.074
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.074
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.074
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.074
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.073
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.071
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.071
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.071
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.070
|
Human |
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.070
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.070
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.069
|
Mouse |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.068
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.068
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.067
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.067
|
|
|
|
cellular water homeostasis
|
GO:0009992 |
2 |
0.067
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.065
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.063
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.063
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.063
|
|
|
|
neutrophil apoptotic process
|
GO:0001781 |
3 |
0.063
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.063
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.063
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.062
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.062
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.062
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.061
|
Human |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.061
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.060
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.060
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.059
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.059
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.058
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.057
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.057
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.057
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.056
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.056
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.056
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.056
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.055
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.055
|
|
|
|
actin filament depolymerization
|
GO:0030042 |
15 |
0.055
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.055
|
Mouse |
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.055
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.055
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.055
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.055
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.055
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.054
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.054
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.053
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.053
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.053
|
Human |
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.052
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.052
|
Mouse |
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.052
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.052
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.051
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.050
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.050
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.049
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.049
|
|
|
|
negative regulation of actin filament depolymerization
|
GO:0030835 |
9 |
0.048
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.048
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.048
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.048
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.048
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.047
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.047
|
|
|
|
myeloid cell apoptotic process
|
GO:0033028 |
22 |
0.047
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.047
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.046
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.046
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.046
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.046
|
Mouse |
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.046
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.046
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.046
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.046
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.045
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.045
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.045
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.045
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.044
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.044
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.044
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.044
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.044
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.044
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.043
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.043
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.043
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.043
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.042
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.042
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.041
|
|
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
3 |
0.041
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.041
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.040
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.039
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.039
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.039
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.039
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.039
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.038
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.038
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.038
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.038
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.038
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.038
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.038
|
|
|
|
barbed end actin filament capping
|
GO:0051016 |
6 |
0.038
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.037
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.037
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.037
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.037
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.036
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.036
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.036
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.036
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.036
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.036
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.035
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.035
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.035
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.035
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.034
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.034
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.034
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.034
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.034
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.034
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.034
|
Human |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.034
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.033
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.033
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.033
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.033
|
|
|
|
icosanoid transport
|
GO:0071715 |
14 |
0.033
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.033
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.033
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.033
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.033
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.032
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.032
|
|
|
|
regulation of myeloid cell apoptotic process
|
GO:0033032 |
19 |
0.032
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.032
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.032
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.032
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.032
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.031
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.031
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.031
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.031
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.030
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.029
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.029
|
|
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
26 |
0.029
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.029
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.029
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.029
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.028
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.028
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.028
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.028
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.028
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.028
|
Mouse |
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.028
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.027
|
Mouse |
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.027
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.027
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.027
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.027
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.027
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.027
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.027
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.027
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.027
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.027
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.026
|
Mouse |
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.026
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.026
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.026
|
Mouse |
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.026
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.026
|
|
|
|
fatty acid derivative transport
|
GO:1901571 |
14 |
0.025
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.025
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.025
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.025
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.025
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.025
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.025
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.025
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.025
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.025
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.025
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.025
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.025
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.025
|
|
|
|
inflammatory cell apoptotic process
|
GO:0006925 |
11 |
0.024
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.024
|
Mouse |
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.024
|
|
|
|
cell volume homeostasis
|
GO:0006884 |
9 |
0.024
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.024
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.024
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.024
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.024
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.024
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.024
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.023
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.023
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.023
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.023
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.023
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.023
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.023
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.023
|
|
|
|
arachidonic acid secretion
|
GO:0050482 |
8 |
0.023
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.023
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.023
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.022
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.022
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.022
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.022
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.022
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.022
|
|
|
|
icosanoid secretion
|
GO:0032309 |
12 |
0.022
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.022
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.022
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.022
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.022
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.022
|
Human |
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.022
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.022
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.022
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.022
|
|
|
|
positive regulation of lamellipodium organization
|
GO:1902745 |
3 |
0.022
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.022
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.022
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.022
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.022
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.022
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.021
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.021
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.021
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.021
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.021
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.021
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.021
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.021
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.021
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.020
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.020
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.020
|
Human |
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.020
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.020
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.020
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.020
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.020
|
|
|
|
regulation of interleukin 1 alpha production
|
GO:0032650 |
4 |
0.020
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.020
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.020
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.020
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.020
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.020
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.019
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.019
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.019
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.019
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.019
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.019
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.019
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.019
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.019
|
Human |
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.019
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.019
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.019
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.019
|
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.018
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.018
|
|
|
|
actin filament capping
|
GO:0051693 |
6 |
0.018
|
|
|
|
regulation of actin filament depolymerization
|
GO:0030834 |
13 |
0.018
|
|
|
|
regulation of arp2 3 complex mediated actin nucleation
|
GO:0034315 |
1 |
0.018
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.018
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.018
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.018
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.018
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.018
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.018
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.018
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.018
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.018
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.018
|
|
|
|
positive regulation of interleukin 1 alpha production
|
GO:0032730 |
4 |
0.018
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.017
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.017
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.017
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.017
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.017
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.017
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.017
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.017
|
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
36 |
0.017
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.017
|
Mouse |
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.017
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.017
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.017
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.016
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.016
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.016
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.016
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.016
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.016
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.016
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.016
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.016
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.016
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.016
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.016
|
Human |
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.016
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.016
|
Human |
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.016
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.016
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.016
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.016
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.016
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.016
|
|
|
|
regulation of interleukin 1 alpha secretion
|
GO:0050705 |
3 |
0.015
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.015
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.015
|
Mouse |
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.015
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.015
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.015
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.015
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.015
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.015
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.015
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.015
|
Mouse |
|
|
male gamete generation
|
GO:0048232 |
285 |
0.015
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.015
|
|
|
|
apoptotic cell clearance
|
GO:0043277 |
17 |
0.015
|
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.015
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.015
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.015
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.015
|
|
|
|
receptor localization to synapse
|
GO:0097120 |
4 |
0.015
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.015
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.015
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.015
|
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.014
|
|
|
|
epithelial cell differentiation involved in mammary gland alveolus development
|
GO:0061030 |
4 |
0.014
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.014
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.014
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.014
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.014
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.014
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.014
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.014
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.014
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.014
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.014
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.014
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.014
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
Human |
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.014
|
|
|
|
cleavage furrow formation
|
GO:0036089 |
2 |
0.014
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
Mouse |
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.014
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.014
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.014
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.014
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.014
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.014
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.014
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.014
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.014
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.014
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.014
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.014
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.014
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.014
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.013
|
Mouse |
|
|
bundle of his development
|
GO:0003166 |
4 |
0.013
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.013
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.013
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.013
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.013
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.013
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.013
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.013
|
|
|
|
t cell homeostasis
|
GO:0043029 |
35 |
0.013
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.013
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.013
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.013
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.013
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.013
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.013
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.013
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.013
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.013
|
|
|
|
negative regulation of necroptotic process
|
GO:0060546 |
9 |
0.013
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.013
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.013
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.013
|
|
|
|
exocyst localization
|
GO:0051601 |
2 |
0.013
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.013
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.013
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.013
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.013
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.013
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.013
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.013
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.012
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.012
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.012
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.012
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.012
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.012
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.012
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.012
|
|
|
|
phagosome maturation
|
GO:0090382 |
4 |
0.012
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.012
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.012
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.012
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.012
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.012
|
|
